StonvexLoading…
StonvexStonvexStonvexCore line items from ENZN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Q1 2025 2025-03-31 |
|---|---|---|
Revenue | $86.54M | $94.19M |
Operating Income | $-4.33M | $-14.40M |
Net Income | $-6.69M | $-13.59M |
EPS (Diluted) | $-0.84 | $-2.65 |
Total Assets | $428.87M | $45.52M |
Total Liabilities | Not available | Not available |
Cash & Equivalents | $28.62M | $44.97M |
Free Cash Flow OCF − CapEx | $-25.30M | $-7.22M |
Shares Outstanding | 14.33M | 74.21M |